Ashley Hall

Ashley Hall

Corporate Officer/Principal at STRUCTURE THERAPEUTICS INC.

Net worth: 2 M $ as of 2026-05-30

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Ms. Ashley F.
Hall
is a Chief Development Officer at Structure Therapeutics, Inc. Ms. Hall was previously employed as a Chief Development Officer by Reneo Pharmaceuticals, Inc., a Senior VP-Global Regulatory Affairs & Policy by Esperion Therapeutics, Inc., a Vice President-Regulatory Affairs by Amgen Rockville, Inc., a Director-World Wide Regulatory Affairs by MedImmune LLC, a Vice President-Regulatory Affairs by CancerVax Corp., a Vice President-Regulatory Affairs by Micromet, Inc., and a Vice President-Regulatory & Clinical Affairs by Revogenex Ltd. She received her undergraduate degree from the University of California San Diego and a graduate degree from the University of San Diego School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-18 155,187 ( 0.11% ) 2 M $ 2026-05-30

Ashley Hall active positions

CompaniesPositionStart
STRUCTURE THERAPEUTICS INC. Corporate Officer/Principal 2024-09-17

Former positions of Ashley Hall

CompaniesPositionEnd
ONKURE THERAPEUTICS, INC. Corporate Officer/Principal 2024-09-12
General Counsel 2012-04-30
General Counsel 2009-07-31
General Counsel -
General Counsel -
See the detail of Ashley Hall's experience

Training of Ashley Hall

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology